Page 176 - David Mitchell News Today

Advocates for affordable diabetes medications are regrouping and reconsidering strategies for legislation to lower the cost of insulin and other diabetes medications after the Senate passed a limited cost-saving measure that will leave out the majority of insulin users.

The drug pricing impact of the Inflation Reduction Act on pharma, however, is likely to be limited for now.

Glasgow is seen by the business as the Scottish hub for IoT

The rooftop pools at Virgin Hotels Nashville, The Standard, Ibiza, and more provide a chance to cool off during urban hotel stays.

A zoning variance for the troubled downtown Wyndham City Centre has been refiled with the Office of Public Works Planning and Zoning Commission.

Mayor wants to bring Wyndham project back to city council, increase number of hotel rooms

The Inflation Reduction Act requires Medicare to negotiate the prices of a small number of prescription drugs.

Large pharmaceutical companies decried the bill, saying it would stifle innovation without stopping inflation.

As Democrats hurry to finalize $739 billion in climate, health care and tax legislation that was revived last week to the surprise of most Washington insiders, business lobbyists and issue advocates are working to support, tweak or derail the bill entirely.

Empowering Medicare to negotiate prices directly with drug makers has been a Democratic goal for 30 years, one the pharmaceutical industry has fought ferociously.